Status:
COMPLETED
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
Lead Sponsor:
Centre for the AIDS Programme of Research in South Africa
Conditions:
HIV Infections
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a randomized, open-label study comparing three existing treatment strategies of ART initiation in HIV/TB co-infected patients: Group 1: early initiation of ART with TB treatment, Group 2: ini...
Eligibility Criteria
Inclusion
- HIV infected patients co-infected with TB
- Receiving any one of the standard anti-TB therapy regimens
- All patients must agree to use contraception since they will be on efavirenz.
Exclusion
- Entry into the treatment programme is based on a clinical assessment and should patients not be clinically eligible to maintain a treatment regimen,their entry may be deferred or precluded
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
642 Patients enrolled
Trial Details
Trial ID
NCT00398996
Start Date
June 1 2005
End Date
July 1 2010
Last Update
March 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CAPRISA eThekwini Clinical Research Site
Durban, KwaZulu-Natal, South Africa, 4001